Saturday, November 27, 2021
Home Tags Dr Reddy’s

Tag: Dr Reddy’s

Pharma companies are awaiting DCGI nod to launch Covid-19 drug in...

MUMBAI: Sun Pharma said on Thursday it is gearing up to introduce antiviral Covid-19 drug, molnupiravir under the brand Molxvir at "an economical price'' in India....

Serum Institute seeks DCGI’s nod to manufacture Sputnik V vaccine

New Delhi: The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V C-19 vaccine for...

Govt to pharma firms: Ramp up Remdesivir Mfg to full capacity

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

DCGI soon to clear way for regular usage authorization of Covaxin

The Drug Control General of India (DCGI) is soon going to remove the ‘trial mode’ tag for Bharat Biotech’s Covaxin C-19 vaccine...

Dr Reddy’s gets DCGI nod for Phase 3 clinical trial for...

Dr Reddy’s Laboratories has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the...

India to produce 300 million Sputnik V vaccines

India will produce about 300 million doses of Russia’s Sputnik V C-19 virus vaccines next year, a Russian official was quoted as...

Dr Reddy’s inks licensing pact with Gilead for Remdesivir

Hyderabad: Indian generic drug maker Dr Reddy’s Laboratories announced entering into a non-exclusive licensing agreement with Gilead Sciences, which grants the Indian firm...

Dr. Reddy’s receives EIR from USFDA

Dr. Reddy's receives EIR from USFDA Dr Reddy's Laboratories Ltd has received the Establishment Inspection Report (EIR) from US...

Dr Reddy’s recalls its heart burn medicine

Dr Reddy’s recalls its heart burn medicine in US Dr Reddy’s Laboratories is recalling 1,752 bottles of generic heartburn...

USFDA seeks voluntary action at Dr Reddy’s

New Delhi: The US health regulator has asked drug major Dr Reddy's Laboratories to initiate voluntary action at its Duvvada facility in Andhra Pradesh.

Dr. Reddy’s launches generic Syprine capsules

Dr. Reddy's Laboratories Ltd announced the launch of the US Food and Drug Administration (FDA) approved trientine hydrochloride capsules USP, 250 mg,...

Latest posts

High Court restrains publishing Ads in a dispute on Chyawanprash

The Calcutta High Court has issued an interim injunction restraining Shree Baidyanath Ayurved Bhawan Pvt Ltd from issuing certain print and video...

Authors

58 POSTS0 COMMENTS
30 POSTS0 COMMENTS
20 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
9 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS